1. Home
  2. ENZ vs PMAX Comparison

ENZ vs PMAX Comparison

Compare ENZ & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • PMAX
  • Stock Information
  • Founded
  • ENZ 1976
  • PMAX 2019
  • Country
  • ENZ United States
  • PMAX Hong Kong
  • Employees
  • ENZ N/A
  • PMAX N/A
  • Industry
  • ENZ Medical Specialities
  • PMAX
  • Sector
  • ENZ Health Care
  • PMAX
  • Exchange
  • ENZ Nasdaq
  • PMAX Nasdaq
  • Market Cap
  • ENZ 34.2M
  • PMAX 32.0M
  • IPO Year
  • ENZ N/A
  • PMAX 2024
  • Fundamental
  • Price
  • ENZ $0.51
  • PMAX $0.42
  • Analyst Decision
  • ENZ
  • PMAX
  • Analyst Count
  • ENZ 0
  • PMAX 0
  • Target Price
  • ENZ N/A
  • PMAX N/A
  • AVG Volume (30 Days)
  • ENZ 125.3K
  • PMAX 4.4M
  • Earning Date
  • ENZ 03-12-2025
  • PMAX 02-21-2025
  • Dividend Yield
  • ENZ N/A
  • PMAX N/A
  • EPS Growth
  • ENZ N/A
  • PMAX N/A
  • EPS
  • ENZ N/A
  • PMAX 0.04
  • Revenue
  • ENZ $30,314,000.00
  • PMAX $5,970,263.00
  • Revenue This Year
  • ENZ N/A
  • PMAX N/A
  • Revenue Next Year
  • ENZ N/A
  • PMAX N/A
  • P/E Ratio
  • ENZ N/A
  • PMAX $10.94
  • Revenue Growth
  • ENZ N/A
  • PMAX 30.05
  • 52 Week Low
  • ENZ $0.51
  • PMAX $0.34
  • 52 Week High
  • ENZ $1.40
  • PMAX $4.70
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 27.86
  • PMAX N/A
  • Support Level
  • ENZ $0.51
  • PMAX N/A
  • Resistance Level
  • ENZ $0.69
  • PMAX N/A
  • Average True Range (ATR)
  • ENZ 0.03
  • PMAX 0.00
  • MACD
  • ENZ -0.00
  • PMAX 0.00
  • Stochastic Oscillator
  • ENZ 17.38
  • PMAX 0.00

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

Share on Social Networks: